GSA Capital Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-44,849
| Closed | -$50K | – | 2061 |
|
|
2022
Q4 | $50K | Sell |
44,849
-52,468
| -54% | -$58.5K | 0.01% | 1359 |
|
|
2022
Q3 | $228K | Buy |
+97,317
| New | +$228K | 0.03% | 1127 |
|
|
2021
Q4 | – | Sell |
-96,900
| Closed | -$720K | – | 1925 |
|
|
2021
Q3 | $720K | Buy |
96,900
+44,277
| +84% | +$329K | 0.07% | 484 |
|
|
2021
Q2 | $358K | Buy |
+52,623
| New | +$358K | 0.04% | 830 |
|
|
2021
Q1 | – | Sell |
-30,696
| Closed | -$215K | – | 1608 |
|
|
2020
Q4 | $215K | Buy |
+30,696
| New | +$215K | 0.04% | 942 |
|
|
2020
Q2 | – | Sell |
-48,169
| Closed | -$229K | – | 1245 |
|
|
2020
Q1 | $229K | Buy |
+48,169
| New | +$229K | 0.06% | 669 |
|
|
2019
Q4 | – | Sell |
-41,912
| Closed | -$140K | – | 1818 |
|
|
2019
Q3 | $140K | Buy |
41,912
+29,625
| +241% | +$99K | 0.02% | 1235 |
|
|
2019
Q2 | $61K | Sell |
12,287
-26,315
| -68% | -$131K | 0.01% | 1375 |
|
|
2019
Q1 | $239K | Sell |
38,602
-93,498
| -71% | -$579K | 0.02% | 1132 |
|
|
2018
Q4 | $445K | Buy |
132,100
+28,000
| +27% | +$94.3K | 0.05% | 619 |
|
|
2018
Q3 | $677K | Buy |
+104,100
| New | +$677K | 0.04% | 924 |
|